|James O'Dell, M.D.|
The group has:
- Pioneered the use of triple therapy to treat RA;
- Described genetic factors that predict response to therapy; and
- Designed and participated in studies to compare the efficacy of conventional and biologic medicines.
Dr. O'Dell also is principal investigator of a large, multinational RA research study through the Veterans Administration's Cooperative Studies Program.
Dr. O'Dell's many scholarly publications include articles on his study of the success of triple therapy and authorship of a review, "Therapeutic Strategies for Rheumatoid Arthritis," in the New England Journal of Medicine.
Congratulations, your hard work and dedication has paid off. I'm telling my Aunt Dixie!
Congrats, Dr. O'Dell, on this national recognition! UNMC is lucky to have you on our team.